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The mission of IUPUI breast cancer center is to address prevention, early detection, and 
treatment of breast cancer through translational projects, supportive cores, and synergistic 
programs. This poster details our efforts improve resources for breast cancer research and efforts 
to develop multi-PI investigator proposals. The Signature Center Initiative has developed two 
web resources: the Breast Cancer Prognostics Database (BCDB) to study prognostic implications 
of genes of interest in publically available breast cancer databases and PROGmiR, a microRNA 
database. The BCDB can be used to study overall, recurrence free and metastasis free survival in 
large patient series. PROGmiR allows investigators to study the prognostic importance of 
microRNAs. PROGmiR has recently been published and has been accessed by investigators 
from several countries. The signature center has also devoted considerable efforts in developing 
tumor tissue resource. Tissue Bank includes a total sample of N = 500 cases with 30% non-
Caucasian cases from Wishard Memorial Hospital. Currently 237 cases have been assembled 
into a Tissue Microarray with clinical and follow up data. The breast cancer center has funded 
three pilot projects. Drs. Clark Wells, S. Badve, and G. Sandusky are collaborating on the 
project: “Histologic Analysis of the Protein Levels of Amot130, AmotL1 and YAP in Normal, 
Hyperplastic and Invasive Breast Cancer Tissues”. This project is investigating localized protein 
expression in paraffin-embedded tissues to associate expression levels with disease subtype and 
patient outcome. Dr. David Gilley and his group are collaborating on the project: “Luminal 
mammary progenitors are a unique site of telomere dysfunction”. This project is investigating the 
relationship between telomere dysfunction and breast cancer tumorigenesis. In the third project, 
Dr. Theresa Guise will be investigating the mechanisms of cancer-associated cachexia. Several 
multi-PI proposals are under preparation and one proposal with Drs. Nakshatri and Kathy Miller 
as PIs is currently under review. 
 
 
 
 
 
